Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email On November 6, 2019, the Federal Trade Commission (“FTC”) voted 5-0 to uphold Administrative Law Judge D. Michael Chappell’s initial decision that Otto Bock HealthCare GmbH’s (“Otto Bock”) acquisition of rival Freedom Innovations LLC (“Freedom”) substantially lessened competition in the market for microprocessor-driven prosthetic knees. Finding that the acquisition already has lessened competition and likely will lead to higher prices and less innovation, the Commission ordered Otto Bock to sell the majority of the Freedom assets to an FTC-approved buyer. https://www.cadwalader.com/resources/clients-friends-memos/buyer-beware-ftc-orders-unwinding-of-a-consummated-transaction